| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/01/2006 | US20060116521 Method for the production of optically active 2-amino 2-chloro, 2 hydroxy or 2-alkoxy-1-alcohols |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116398 E.g., biphenyl-2-ylcarbamic acid 1-{9-[2-(4-hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)ethylamino]nonyl}piperidin-4-yl ester;respiratory system disorders; bronchodilators; chronic obstructive pulmonary disease or asthma; affinity for dopamine D2 receptors; used with phosphodiesterase-4 inhibitor |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | CA2595602A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
| 06/01/2006 | CA2589258A1 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 06/01/2006 | CA2586096A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 05/31/2006 | EP1661900A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660445A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660440A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1485343A4 Amorphous hmg-coa reductase inhibitors of desired particle size |
| 05/31/2006 | EP1401821A4 Novel phenylalkyl diamine and amide analogs |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1251822A4 Novel coupler for use in oxidative hair dyeing |
| 05/31/2006 | EP1212540B1 Locking nut, bolt and clip systems and assemblies |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | EP0885228B1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 05/31/2006 | CN1780817A Aminocyclohexyl ether compounds and uses thereof |
| 05/31/2006 | CN1780815A Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 05/31/2006 | CN1780813A Acid generators, sulfonic acids, sulfonyl halides, and radiation-sensitive resin compositions |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053170 Preparation of high molecular weight polysuccinimides |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/26/2006 | WO2006055565A2 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives |
| 05/26/2006 | WO2006054426A1 Hydrophobic fluorescent probe of high-fluorescent quantum efficiency type, and method of detecting biopolymer and method of detecting interaction between biopolymers by using the same |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | WO2006053441A1 Improved process for the preparation of (s)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| 05/26/2006 | WO2006014549A3 Synthesis of azo bonded immunoregulatory compounds |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/26/2006 | WO2005070884A3 Heterocyclic compounds useful as growth hormone secretagogues |
| 05/26/2006 | CA2587495A1 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/25/2006 | US20060111429 Novel compounds |
| 05/25/2006 | US20060111352 Acetylenic compounds useful in treating inflammatory disorders |
| 05/25/2006 | US20060111336 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1659110A1 Process for the production of atorvastatin calcium un amorphous form |
| 05/24/2006 | EP1658283A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1658066A2 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/24/2006 | EP1379676B1 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols |
| 05/24/2006 | CN1777663A Organic electroluminescent devices and metal complex compounds |
| 05/24/2006 | CN1777601A Nk-2 antagonist basic linear compounds and formulations containing them |
| 05/24/2006 | CN1777581A Remedy for diabetes |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775825A Polyaspartimides |
| 05/24/2006 | CN1775753A N,N-dialkyl-2-pyrrolidone quaternary ammonium salt and its synthesizing method and use |
| 05/24/2006 | CN1775752A Optical pure diamide compound and its use |
| 05/24/2006 | CN1257158C N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity |
| 05/23/2006 | US7049446 Process for chemical reaction of amino acids and amides yielding selective conversion products |
| 05/23/2006 | US7049378 Polymerization of olefin |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/18/2006 | WO2006051937A1 Five-membered heterocyclic derivatives |
| 05/18/2006 | WO2006051399A1 Piperazine derivatives useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006051047A1 N-substituted imides as polymerization initiators |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106232 atorvastatin hemi-calcium Form X and solvates of given powder X-ray diffraction pattern; small particle size distribution; dosage forms |
| 05/18/2006 | US20060106231 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/18/2006 | US20060106230 Processes for preparing amorphous atorvastatin hemi-calcium |
| 05/18/2006 | US20060106229 Synthesis of amino acid, N-carboxyanhydrides |
| 05/18/2006 | US20060106228 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106194 Polyaspartimides |
| 05/18/2006 | US20060106111 Phenylnaphthalene compounds |
| 05/18/2006 | US20060106087 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106018 treating or ameliorating a reactive oxygen species mediated inflammatory disorder as interleukin-2 mediated disorder, inflammatory arthritis, Alzheimer's disease; inhibitors of nicotinamide adenine dinucleotide oxidase; N1-[2-[4-[(4-chlorophenyl)ethynyl]phenoxy]ethyl]-N4-propyl-1,4-benzenedimethanamine |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | CA2586752A1 Substituted pyrrolidone compounds as ep4 agonists |
| 05/17/2006 | EP1657237A1 Process for production of cis-4-fluoro-l-proline derivatives |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/17/2006 | CN1774421A Process for preparing 5-(4- fluorophenyl)- 1-[2r, 4r) -4-hydroxy-6-oxo- tetrahydro-pyran -2-yl) ethyl]-2 -isopropyl -4-phenyl- 1h-pyrrole-3 -carboxylic acid phenylamide |
| 05/17/2006 | CN1774420A Process for the preparation of N-substituted 2-cyanopyrrolidines |
| 05/17/2006 | CN1774419A Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/17/2006 | CN1772749A Fungicides for the control of take-all disease of plants |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/16/2006 | US7045647 Synergistic mixture of a nitroxyl compound with a quinone alkide having an electron withdrawing group at the 7-position; purification of unsaturated compounds; effective during steady state and after shutoff; storage stability |